Analyzing...
Loading company...
Nothing flagged for monitoring
No significant strengths identified from available data
“Operates in Healthcare — Equipment & Devices.”
₹392 Cr revenue.
COGS 33.0%, employees 16.7%.
“revenues grew 12.”
“Peak revenue potential is 350 to 400 crores from new capacity. 100 to 125 crores from capacity expansion, rest from new products.”
“revenue for q three after twenty six is stood at around 84 crore, and revenue for nine months FY '26 stood at rupee for $2.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 3.3%▼ | 12.3% |
| ROCE | 5.8%▼ | 15.3% |
| Net Margin | 4.7%▼ | 8.5% |
| EBITDA Margin | 32.3%▲ | 14.9% |
| Debt To Equity | 0.61x▲ | 0.10x |
| Rev Growth 3yr | 9.7%▼ | 15.2% |
| EPS Growth 3yr | -33.4%▼ | -17.4% |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2022 |
|---|---|---|---|---|
| Revenue | ₹414 Cr +5.6% | ₹392 Cr +32.4% | ₹296 Cr -1.5% | ₹301 Cr |
| Other Income | ₹21 Cr +33.7% | ₹16 Cr +39.1% | ₹11 Cr +35.5% | ₹8 Cr |
| Total Income | ₹436 Cr +6.7% | ₹408 Cr +32.6% | ₹308 Cr -0.5% | ₹309 Cr |
| COGS | ₹136 Cr +4.7% | ₹129 Cr +57.5% | ₹82 Cr +30.7% | ₹63 Cr |
| ₹403 Cr +10.7% | ₹364 Cr +47.1% | ₹247 Cr +41.8% | ₹174 Cr | |
| Profit Before Tax | ₹32 Cr -29.2% | ₹45 Cr -26.3% | ₹61 Cr -55.0% | ₹135 Cr |
| Exceptional Items | (₹1 Cr) | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹11 Cr -24.4% | ₹15 Cr -17.1% | ₹18 Cr -47.2% | ₹34 Cr | |
| Net Profit | ₹20 Cr -31.7% | ₹30 Cr -30.2% | ₹43 Cr -57.6% | ₹101 Cr |
| Profit (Owners) | ₹20 Cr -31.7% | ₹30 Cr -30.2% | ₹43 Cr -57.6% | ₹101 Cr |
| Other Comprehensive Income | (₹12 Cr) -564.2% | (₹2 Cr) ↓ Decline | ₹0.92 Cr +346.6% | ₹0.21 Cr |
| EPS | ₹3.83 | ₹5.60 | ₹8.01 | ₹18.92 |
| Diluted Shares | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Tarsons Products Limited has informed the Exchange about Schedule of meet
Tarsons Products Limited has informed the Exchange about Schedule of meet
Tarsons Products Limited has informed the Exchange about Transcript
Tarsons Products Limited has informed the Exchange about Copy of Newspaper Publication
Tarsons Products Limited has informed the Exchange regarding 'Approval of the Audited (Standalone and Consolidated) Financial Results for the quarter and financial year ended March 31, 2026'.
Tarsons Products Limited has informed the Exchange regarding Change in Auditors of the company.
Tarsons Products Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Tarsons Products Limited has informed the Exchange about Schedule of meet
Tarsons Products Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Tarsons Products Limited has informed the Exchange about Copy of Newspaper Publication
Tarsons Products Limited has informed the Exchange regarding Notice of Postal Ballot
Tarsons Products Limited has informed the Exchange about Transcript
Tarsons Products Limited has informed the Exchange about Schedule of meet
Tarsons Products Limited has informed the Exchange about Copy of Newspaper Publication
Tarsons Products Limited has informed the Exchange about Link of Recording